Trading is risicovol
Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect.
Trading is risicovol
Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect.
Balchem Corp
Gesloten
SectorGrondstoffen
158.84 -0.27
Overzicht
Wijziging aandelenprijs
24u
Min
156.2
Max
159.32
Inkomsten | 1.2M 38M |
|---|---|
Verkoop | 4.9M 255M |
K/W Sectorgemiddelde | 34.841 102.306 |
EPS | 1.22 |
Dividendrendement | 0.57 |
Winstmarge | 14.984 |
Werknemers | 1,364 |
EBITDA | -21M 41M |
Aanbevelingen | Buy |
|---|---|
12 Maanden Prognose | +16.42% upside |
Dividendrendement Sectorgemiddelde | 0.57% 3.48% |
|---|---|
Volgende Winsten | 24 okt 2025 |
Marktkapitalisatie | 130M 5B |
|---|---|
Vorige openingsprijs | 159.11 |
Vorige sluitingsprijs | 158.84 |
Nieuwssentiment
By Acuity
15%
85%
7 / 168 Rangschikking in Basic materials
Technische score
By Trading Central
Vertrouwen
Very Strong Bullish Evidence
Balchem Corp Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Gerelateerd nieuws
Peer Vergelijking
Prijswijziging
Balchem Corp Prognose
Koersdoel
By TipRanks
16.42% opwaarts potentieel
12 Maanden Prognose
Gemiddelde 185.5 USD 16.42%
Hoogste 189 USD
Laagste 182 USD
Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Balchem Corp - Dist. in de afgelopen 3 maanden.
Sentiment
By Acuity
7 / 168 Rangschikking in Grondstoffen
Nieuwssentiment
Zeer Sterk Bearish Bewijs
Volatiliteit
Onder gemiddelde
Nieuws Volume (RCV)
Boven gemiddelde
Financieel
Verkoop- en administratiekosten
Bedrijfskosten
Winst voor belastingen
Verkoop
Kosten van verkopen
Brutowinst op verkopen
Rente-uitgaven op schulden
EBITDA
Operationele winst
$
Over Balchem Corp
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
